Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 8/20 | 0.47 |
| ▸ | LPL | P06858 | 7/20 | 0.47 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | P4HB | P07237 | 1/20 | 0.31 |
| ▸ | ANPEP | P15144 | 1/20 | 0.30 |
| ▸ | LAP3 | P28838 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | CASP3 | P42574 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.30 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.30 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24319012 | 0.86 | KDM4E (0.41) | LIPGLPLMAPT | |
| SCHEMBL24319006 | 0.80 | CYP2A6 (0.41) | LIPGLPLNPC1MAPTRAB9A | |
| SCHEMBL18462204 | 0.78 | LIPG (0.58) | LIPGLPLDGAT1P4HBANPEP | |
| SCHEMBL25896115 | 0.78 | LIPG (0.44) | LIPGLPLANPEPLAP3 | |
| SCHEMBL24318332 | 0.74 | PDE10A (0.37) | LIPGLPLNPC1MAPTHPGD | |
| SCHEMBL25825013 | 0.73 | LIPG (0.42) | LIPGLPL | |
| SCHEMBL16901203 | 0.73 | LIPG (0.42) | LIPGLPLANPEPLAP3 | |
| SCHEMBL31469310 | 0.72 | LIPG (0.47) | LIPGLPLDGAT1P4HBANPEP | |
| SCHEMBL21612973 | 0.71 | LIPG (0.50) | LIPGLPLDGAT1P4HBANPEP | |
| SCHEMBL18462118 | 0.71 | LIPG (0.50) | LIPGLPLDGAT1P4HBANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220098217-A1 | COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | LT MATERIALS CO., LTD. (KR) | 2022-03-31 | — | — | US | disclosed |
| WO-2020159249-A1 | COMPOSITION, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | 엘티소재주식회사 | 2020-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220098217-A1 | COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | AOX1, OXER1, OR51E2 | LIPG 1661/4885LPL 1850/4885DGAT1 359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.